Search results
Prescription drug prices have surged almost 40% over the past decade
FOX Business· 1 day agoThe cost of prescription drugs in the U.S. has surged nearly 40% over the past decade, easily...
Step inside Boots and the only sign of life is the long queue for prescriptions
Daily Telegraph· 1 day ago“While we believe there is significant interest in Boots at the right time, its growth, strategic...
Work is getting really weird
Business Insider· 2 days agoThe use of shadow stand-ins and a lack of promotions are the latest trends that show how weird work has gotten.
People aren't spending like they used to and it's forcing companies like Nike and Walgreens to make...
Business Insider· 4 days agoThis story is available exclusively to Business Insider subscribers. Become an Insider and start...
Why your local pharmacy may be closing
Business Insider· 5 days agoThis story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. Walgreens plans to close a "significant"...
Forbes Daily: Walgreens Feels The Pain As Retail Pharmacies Struggle
Forbes· 5 days agoIf you’ve been saving up hotel or airline reward points for a summer vacation, you may want to...
Millions to face shock jump in mortgages repayments over the next two years
The Sun· 6 days agoWet weather, the cost of living and hefty discounting by rivals mean bike sales now make up less...
Supreme Court Rejects Purdue Pharma Opioid Settlement - What’s News - WSJ Podcasts
The Wall Street Journal· 6 days agoAnna Mathews: Pharmacies are increasingly saying they just don't actually make enough on filling prescriptions to survive. Sabrina Siddiqui: Plus, a newly discovered species ...
Boots crisis deepens as US owner announces plans to axe stores
This Is Money· 6 days agoBoots is facing an increasingly uncertain future as the crisis that is engulfing its American owner deepens. In a bleak update to investors on Wall Street yesterday, Walgreens
Beware Royal Mail debt pile, says ALEX BRUMMER
This Is Money· 6 days agoThere are many reasons for opposing the ‘Czech Sphinx’ bid for International Distributions Services (IDS), the owner of the Royal Mail. Public-to-private deals are destabilising and opaque, ...